Seroatlas · Human Serome Atlas

SPA17

Sperm surface protein Sp17

Also known as: CT22, SP17, SP17_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q15506
Gene
SPA17
Ensembl
ENSG00000064199
Chromosome
11
Canonical length
151 aa
Protein class
Predicted intracellular proteins
Subcellular location
Golgi apparatus,Vesicles,Principal piece
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes a protein present at the cell surface. The N-terminus has sequence similarity to human cAMP-dependent protein kinase A (PKA) type II alpha regulatory subunit (RIIa) while the C-terminus has an IQ calmodulin-binding motif. The central portion of the protein has carbohydrate binding motifs and likely functions in cell-cell adhesion. The protein was initially characterized by its involvement in the binding of sperm to the zona pellucida of the oocyte. Recent studies indicate that it is also involved in additional cell-cell adhesion functions such as immune cell migration and metastasis. A retrotransposed pseudogene is present on chromosome 10q22.[provided by RefSeq, Jan 2009]

Canonical amino-acid sequenceUniProt

151 residues, UniProt reviewed canonical sequence.

>Q15506|SPA17
     1  MSIPFSNTHY RIPQGFGNLL EGLTREILRE QPDNIPAFAA AYFESLLEKR EKTNFDPAEW
    61  GSKVEDRFYN NHAFEEQEPP EKSDPKQEES QISGKEEETS VTILDSSEED KEKEEVAAVK
   121  IQAAFRGHIA REEAKKMKTN SLQNEEKEEN K

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SPA17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.51
Highest tissue expression
37 nTPM

Expression across tissuesHPA

Tissue

  • testis: 37 nTPM
  • fallopian tube: 23 nTPM
  • choroid plexus: 15 nTPM
  • epididymis: 10 nTPM
  • thyroid gland: 6.3 nTPM
  • parathyroid gland: 4.4 nTPM

Single-cell type

  • late spermatids: 3,590 nCPM
  • late primary spermatocytes: 1,869 nCPM
  • early spermatids: 1,487 nCPM
  • fallopian tube ciliated cells: 537 nCPM
  • respiratory ciliated cells: 477 nCPM
  • endometrial ciliated cells: 397 nCPM

Immune cell

  • non-classical monocyte: 0.6 nTPM
  • basophil: 0.5 nTPM
  • myeloid DC: 0.4 nTPM
  • classical monocyte: 0.3 nTPM
  • intermediate monocyte: 0.2 nTPM
  • memory B-cell: 0.1 nTPM

Brain region

  • choroid plexus: 17 nTPM
  • midbrain: 8.6 nTPM
  • medulla oblongata: 8.4 nTPM
  • spinal cord: 6.4 nTPM
  • thalamus: 5.2 nTPM
  • white matter: 5.1 nTPM

ReferencesPubMed · IEDB

Publications for SPA17 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.4
gnomAD pLI
0.01
gnomAD missense Z
-0.16
DepMap mean gene effect
0.1
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SPA17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SPA17 as an antibody target. Whether an autoantibody or antibody against SPA17 could matter depends on whether native SPA17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SPA17 is annotated at the cell surface, where native SPA17 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SPA17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SPA17. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...